Sarcopenia and Multimodal Rehabilitation on the Prognosis of Rectal Cancer Patients Receiving CCRT

Chang Gung Medical Foundation

Status: Not yet enrolling

Conditions: Rectal Cancer

Treatments: Other: for excise, nutrition consultant, nutrition supplement and psychologic intervention.

Study type: Interventional

Funder types: Other

Identifiers

NCT05664607

202200748A3

Details and patient eligibility

About

Investigators use clinical trial to explore the role of sarcopenia and multimodal rehabilitation in prognosis of rectal cancer patients receiving concurrent chemoradiotherapy.

Full description

The impact of sarcopenia and the effect of multimodal rehabilitation will be evaluated in the rectal cancer patients receiving pre-operative concurrent chemoradiotherapy. This is a randomized trial.

Enrollment: 100 estimated patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age>20
• rectal cancer patients receiving concurrent chemoradiotherapy
• agree to join the trial and sign the informed consent form

Exclusion criteria

• unstable vital sign
• unable to excise
• not suitable after evaluation by Principal Investigator

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

control group

No Intervention group

Description:

no multimodal rehabilitation

multimodal rehabilitation group

Experimental group

Description:

include excise, nutrition consultant, nutrition supplement and psychologic intervention.

Treatment:

Other: for excise, nutrition consultant, nutrition supplement and psychologic intervention.